ROIV
Roivant Sciences Ltd.Company with tickers: ROIV
CIK
1635088
CUSIP
G76279101
Shares Outstanding
715,701,137
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-31 | Torti Frank | President and Vant Chair | Tax | 160,035 |
| 2026-03-31 | Gline Matthew | Director, CEO | Tax | 304,684 |
| 2026-03-31 | Sukhatme Mayukh | Director, President & CIO | Tax | 187,512 |
| 2026-03-30 | Gline Matthew | Director, CEO | Convert | 2,178,150 |
| 2026-03-30 | Gline Matthew | Director, CEO | Convert | 97,319 |
| 2026-03-30 | Gline Matthew | Director, CEO | Tax | 53,826 |
| 2026-03-30 | Sukhatme Mayukh | Director, President & CIO | Tax | 29,809 |
| 2026-03-30 | Sukhatme Mayukh | Director, President & CIO | Convert | 58,391 |
| 2026-03-30 | Sukhatme Mayukh | Director, President & CIO | Convert | 1,306,889 |
| 2026-03-26 | Fitzgerald Meghan | Director | Sell | 70,000 |
| 2026-03-26 | Fitzgerald Meghan | Director | Convert | 70,000 |
| 2026-03-26 | Fitzgerald Meghan | Director | Convert | 70,000 |
| 2026-03-20 | Pulik Richard | CFO | Tax | 1,546 |
| 2026-03-20 | Humes Jennifer | Chief Accounting Officer | Tax | 14,526 |
| 2026-03-17 | Venker Eric | President & Immunovant CEO | Sell | 200,000 |
| 2026-03-17 | Venker Eric | President & Immunovant CEO | Convert | 200,000 |
| 2026-03-17 | Venker Eric | President & Immunovant CEO | Convert | 200,000 |
| 2026-03-16 | Epperly Melissa B, | Director | Sell | 41,861 |
| 2026-02-23 | Torti Frank | President and Vant Chair | Sell | 587,390 |
| 2026-02-23 | Torti Frank | President and Vant Chair | Convert | 587,390 |
| 2026-02-23 | Torti Frank | President and Vant Chair | Convert | 587,390 |
| 2026-02-20 | Pulik Richard | CFO | Tax | 1,000 |
| 2026-02-20 | Torti Frank | President and Vant Chair | Convert | 1,012,610 |
| 2026-02-20 | Torti Frank | President and Vant Chair | Convert | 1,012,610 |
| 2026-02-20 | Venker Eric | President & Immunovant CEO | Tax | 7,051 |
| 2026-02-20 | Torti Frank | President and Vant Chair | Sell | 1,012,610 |
| 2026-02-19 | Torti Frank | President and Vant Chair | Convert | 1,400,000 |
| 2026-02-19 | Torti Frank | President and Vant Chair | Convert | 1,400,000 |
| 2026-02-19 | Torti Frank | President and Vant Chair | Sell | 1,400,000 |
| 2026-02-13 | Gold Daniel Allen | Director | Sell | 150,784 |
| 2026-02-13 | Venker Eric | President & Immunovant CEO | Sell | 200,000 |
| 2026-02-13 | Venker Eric | President & Immunovant CEO | Convert | 200,000 |
| 2026-02-13 | Venker Eric | President & Immunovant CEO | Convert | 200,000 |
| 2026-02-13 | MANCHESTER KEITH S | Director | Sell | 150,784 |
| 2026-02-13 | QVT Financial LP | Insider | Sell | 150,784 |
| 2026-02-12 | Gold Daniel Allen | Director | Sell | 150,000 |
| 2026-02-12 | MANCHESTER KEITH S | Director | Sell | 150,000 |
| 2026-02-12 | QVT Financial LP | Insider | Sell | 150,000 |
| 2026-02-11 | Gold Daniel Allen | Director | Sell | 425,000 |
| 2026-02-11 | MANCHESTER KEITH S | Director | Sell | 425,000 |
| 2026-02-11 | QVT Financial LP | Insider | Sell | 425,000 |
| 2026-02-09 | Sukhatme Mayukh | Director, President & CIO | Other | 312,117 |
| 2026-02-09 | Sukhatme Mayukh | Director, President & CIO | Convert | 651,558 |
| 2026-02-09 | Sukhatme Mayukh | Director, President & CIO | Sell | 339,441 |
| 2026-02-09 | Sukhatme Mayukh | Director, President & CIO | Convert | 651,558 |
| 2026-01-20 | MOMTAZEE JAMES C | Director | Tax | 122 |
| 2026-01-20 | MOMTAZEE JAMES C | Director | Award | 609 |
| 2026-01-20 | Oren Ilan | Director | Award | 1,164 |
| 2026-01-20 | Oren Ilan | Director | Tax | 124 |
| 2026-01-20 | Epperly Melissa B, | Director | Award | 815 |
| 2026-01-20 | Epperly Melissa B, | Director | Tax | 54 |
| 2026-01-12 | Venker Eric | President & Immunovant CEO | Convert | 200,000 |
| 2026-01-12 | Venker Eric | President & Immunovant CEO | Sell | 200,000 |
| 2026-01-12 | Venker Eric | President & Immunovant CEO | Convert | 200,000 |
| 2025-12-31 | Sukhatme Mayukh | Director, President & CIO | Convert | 2,449,877 |
| 2025-12-31 | Sukhatme Mayukh | Director, President & CIO | Other | 1,430,882 |
| 2025-12-31 | Sukhatme Mayukh | Director, President & CIO | Convert | 2,449,877 |
| 2025-12-31 | Sukhatme Mayukh | Director, President & CIO | Sell | 1,018,995 |
| 2025-12-29 | Sukhatme Mayukh | Director, President & CIO | Convert | 748,358 |
| 2025-12-29 | Sukhatme Mayukh | Director, President & CIO | Convert | 748,358 |
| 2025-12-29 | Sukhatme Mayukh | Director, President & CIO | Sell | 311,873 |
| 2025-12-29 | Sukhatme Mayukh | Director, President & CIO | Other | 436,485 |
| 2025-12-24 | Torti Frank | President and Vant Chair | Other | 64,891 |
| 2025-12-24 | Torti Frank | President and Vant Chair | Gift | 110,489 |
| 2025-12-24 | Venker Eric | President & Immunovant CEO | Convert | 117,848 |
| 2025-12-24 | Venker Eric | President & Immunovant CEO | Sell | 75,000 |
| 2025-12-24 | Venker Eric | President & Immunovant CEO | Convert | 117,848 |
| 2025-12-23 | Torti Frank | President and Vant Chair | Award | 175,380 |
| 2025-12-23 | Pulik Richard | CFO | Convert | 260,000 |
| 2025-12-23 | Pulik Richard | CFO | Convert | 260,000 |
| 2025-12-23 | Pulik Richard | CFO | Sell | 260,000 |
| 2025-12-23 | Venker Eric | President & Immunovant CEO | Convert | 313,841 |
| 2025-12-23 | Venker Eric | President & Immunovant CEO | Sell | 200,000 |
| 2025-12-23 | Venker Eric | President & Immunovant CEO | Convert | 313,841 |
| 2025-12-20 | Pulik Richard | CFO | Tax | 2,129 |
| 2025-12-17 | Sukhatme Mayukh | Director, President & CIO | Sell | 26,831 |
| 2025-12-17 | Sukhatme Mayukh | Director, President & CIO | Convert | 59,513 |
| 2025-12-17 | Sukhatme Mayukh | Director, President & CIO | Other | 32,682 |
| 2025-12-17 | Gold Daniel Allen | Director | Sell | 432,718 |
| 2025-12-17 | MANCHESTER KEITH S | Director | Sell | 432,718 |
| 2025-12-17 | QVT Financial LP | Insider | Sell | 432,718 |
| 2025-12-16 | Gold Daniel Allen | Director | Sell | 275,000 |
| 2025-12-16 | MANCHESTER KEITH S | Director | Sell | 275,000 |
| 2025-12-16 | QVT Financial LP | Insider | Sell | 275,000 |
| 2025-12-15 | Gline Matthew | Director, CEO | Convert | 234,096 |
| 2025-12-15 | Gline Matthew | Director, CEO | Convert | 234,096 |
| 2025-12-15 | Gline Matthew | Director, CEO | Other | 3,739 |
| 2025-12-15 | Gline Matthew | Director, CEO | Sell | 230,357 |
| 2025-12-15 | Ramaswamy Vivek | 10% Owner | Sell | 353,745 |
| 2025-12-15 | Ramaswamy Vivek | 10% Owner | Convert | 832,453 |
| 2025-12-15 | Ramaswamy Vivek | 10% Owner | Other | 478,708 |
| 2025-12-15 | Ramaswamy Vivek | 10% Owner | Convert | 832,453 |
| 2025-12-12 | Roivant Sciences Ltd. | Director, 10% Owner | Buy | 16,666,666 |
| 2025-12-12 | Ramaswamy Vivek | 10% Owner | Sell | 1,975,858 |
| 2025-12-12 | Ramaswamy Vivek | 10% Owner | Other | 2,696,866 |
| 2025-12-12 | Ramaswamy Vivek | 10% Owner | Convert | 4,672,724 |
| 2025-12-12 | Ramaswamy Vivek | 10% Owner | Convert | 4,672,724 |
| 2025-12-11 | Ramaswamy Vivek | 10% Owner | Convert | 1,869,691 |
| 2025-12-11 | Ramaswamy Vivek | 10% Owner | Sell | 774,142 |
| 2025-12-11 | Ramaswamy Vivek | 10% Owner | Other | 1,095,550 |